During the past decade, Community Health Network conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 3 clinical trials were completed, i.e. on average, 9.7% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 3 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Health Network" #1 sponsor was "Amgen" with 3 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Seagen Inc." with 3 trials sponsored, "ImmunoGen, Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Health Network" #1 collaborator was "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 3 trials as a collaborator, "Gynecologic Oncology Group" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Community Health Network" are "Breast Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Endometrial Cancer" (3 trials), "Epithelial Ovarian Cancer" (3 trials) and "Fallopian Tube Cancer" (3 trials). Many other conditions were trialed in "Community Health Network" in a lesser frequency.

Most popular intervention types in "Community Health Network" are "Drug" (29 trials), "Biological" (2 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (3 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials), "Carboplatin" (2 trials) and "Pegylated liposomal doxorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Community Health Network" are 31 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Community Health Network". undefined are not yet recruiting, 15 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Community Health Network, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Community Health Network, 12 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".